Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas.

 Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts.

Type
Public
HQ
Billerica, US
Founded
2000
Size (employees)
647 (est)
Insulet Corporation was founded in 2000 and is headquartered in Billerica, US

Insulet Corporation Office Locations

Insulet Corporation has offices in Billerica, Nashville, St. Louis, Tulsa and in 12 other locations
Billerica, US
St. Louis, US
Tulsa, US
Chicago, US
San Francisco, US
Kansas City, US
Oakville, CA
Nashville, US
Pittsburgh, US
Charlotte, US
San Diego, US
Columbus, US
Washington, US
Denver, US
Ontario, US

Insulet Corporation Metrics

Insulet Corporation Summary

Market capitalization

$2.64 B

Closing share price

$45.3
Insulet Corporation's current market capitalization is $2.64 B.

Insulet Corporation Market Value History

Market Position – diabetes, Technology, healthtech, Manufacturing & Industrial, manufacturer, Health, medical devices

Insulet Corporation Online Presence

Insulet Corporation Company Life

You may also be interested in